Understanding home high-flow therapy

High-flow therapy can provide effective relief of chronic COPD symptoms, like cough with mucous production, that can be difficult to manage with standard therapies alone. Learn about the key features and mechanisms of action of this respiratory therapy and discover how it can be used alongside or as an alternative to other treatments for COPD.

On this page, we refer exclusively to nasal home high-flow therapy, which is administered through a nasal cannula.

Home HFT and the GOLD COPD treatment pathway

HFT has benefits for hypoxemic COPD patients with frequent exacerbations in GOLD stages C and D*.1,6,7 GOLD B COPD patients could also benefit from symptom relief.6 HFT can be used with or without oxygen.

Home HFT and the GOLD COPD treatment pathway illustration

Key features of home high-flow therapy

HFT is designed to be administered via a nasal high-flow cannula (NHFC).  This delivers a humidified mixture of air, with or without oxygen, that’s warmed to between 31°C and 37°C. Home HFT can supply flow ranging from 10 L/min to 60L/min. If oxygen is added, it can be delivered at up to 15 L/min. The configuration used depends on the needs of the patient.


High-flow mechanisms of action

Improved secretion management

Because HFT improves ventilation, it helps patients to take deeper breaths, which can help them to clear secretions. Inhaling warm humidified air can also make secretions more fluid and easier to clear. Together, these mechanisms increase patient comfort by preventing secretions from accumulating and reducing obstruction of the airways and cough.1

Reduced dyspnoea

HFT increases nasal inspiratory flow, which reduces nasal resistance. The higher flow also introduces more fresh air into the airways, improving dyspnoea and reducing work of breathing.2-4 Patients’ energy levels can also improve as a result of more oxygen reaching the lungs and body.

Reduction of dead space

Increased flow helps to achieve washout of the upper airways. This improves ventilation by expelling CO2 and reducing dead space.5

Improved patient comfort

Both the interface and the therapy delivery mechanism of HFT support patient comfort. Because it is an open system, there are no issues with constant pressure and mask fit. Patients can talk and eat during therapy. HFT has an immediate and direct impact on secretions1 and work of breathing5 and provides rapid relief to the patient.

Optional supplemental oxygen delivery

Oxygen can be added through the HFT device from an oxygen concentrator with continuous flow, an oxygen cylinder at home or a wall supply in the hospital. It mixes with the air flow, allowing the patient to receive a constant amount of oxygen while simultaneously benefiting from the humidified and heated air which forms the basis of HFT treatment.

LTOT, home HFT and home NIV therapy: similarities and differences

LTOT, home HFT and home NIV can be used separately or in combination for the home-based treatment of COPD patients.

  • LTOT, HFT and home NIV can all improve oxygenation, reduce work of breathing and decrease cardiac load.
  • HFT and home NIV can also improve tidal volume, decrease respiratory rate and improve PEEP.
  • HFT can improve mucosal clearance and dead space clearance, which promotes comfort and tolerance.
  • Home NIV helps COPD patients to benefit from improved alveolar ventilation and unloaded respiratory muscles.

Understanding the difference between hospital high-flow oxygen therapy (HFOT) and home HFT

Hospitals commonly use high-flow oxygen therapy for acute patients as an alternative to mechanical ventilation.

HFOT delivers high concentrations of oxygen and needs to be highly humidified to prevent it from feeling too dry and uncomfortable.

With home HFT, the aim is to help chronic patients to breathe more easily by providing them with heated, humidified air.

Oxygen is not a key component of HFT but it can be added if the patient has a prescription for long-term oxygen therapy (LTOT).

Who, When, What: HFT in practice


Who can benefit from high-flow therapy at home?

High-flow therapy can be indicated for home use in COPD patients affected by chronic cough with mucous production.1,6


When can high-flow therapy be used?

High-flow therapy can be used at home during the day and/or at night. It can be used while patients are talking, eating and sleeping. Because the heated humidifier contains water, care must be taken when moving the device. Patients can place their therapy device on a stable surface and continue to enjoy day-to-day activities, such as reading and watching TV. HFT can also be used to aid recovery after an effort such as climbing stairs or getting ready for the day. Discover how healthcare professionals are using home HFT for COPD.


What are the main features of a home HFT device?

HFT devices are made up of an air inlet, an oxygen port (with or without blender), a flow generator, a humidifier and a heater. Heated tubing is used to maintain heat and humidity levels and manage condensation. The patient interface for nasal HFT is a non-occluding nasal cannula. Home devices are designed to be easy to operate and may support remote monitoring.

Home high-flow therapy FAQs

Are you wondering whether home HFT could be a good option for your patients? HFT is a promising therapy that can raise a lot of questions. In these videos, Dr Maxime Patout and Dr Chris Carlin share their thoughts about HFT and use their experience to answer common queries.

Yes. High-flow therapy systems have been designed for home use. The blower is located on the inside, and the design supports easy operation and training for home use.

Humidification plays a major role in HFT as it increases patient comfort and tolerability. Without humidification to condition the gases, HFT would be uncomfortably cold and dry.

Home high-flow therapy can be used during the day and/or at night. Hours of usage vary depending on the needs and condition of the patient.

According to an internal ResMed survey, 77% healthcare professionals prescribed home HFT to hypoxemic COPD patients for 8 or more hours in a day. 10

Home HFT can be indicated for hypoxemic COPD patients affected by chronic cough with mucous production. Learn more about research into HFT for this target population here.

No. HFT can be considered as a complementary therapy depending on the patient’s needs. This section explains the differences between HFT and PAP therapies.

High-flow therapy can be delivered with or without additional oxygen, depending on the needs of the patient. Oxygen can be added at flow rates of up to 15 L/min.

HFT is not suitable for hypercapnic patients as it does not provide ventilation or pressure support. Nevertheless, hypercapnic patients who use non-invasive ventilation (NIV) may find that HFT increases their comfort levels during their break off NIV.9

HFT does not provide ventilation or pressure support for patients who are experiencing problems with or a failure of their respiratory system. This section explains the differences between HFT and PAP therapies. You can learn more about mechanical ventilation here and CPAP here.

HFT can deliver an adjustable flow of 10-60L/min at a temperature of 31-37°C. Humidification levels can also be adjusted to improve comfort and manage condensation.

Research shows that HFT can start to have a noticeable effect after 1-2 hours of use6,7 and that around 6 hours of use, mainly during the night, could be a suitable daily target.6

Yes​, high-flow therapy can be used while patients are sleeping and when they are awake. 77% of healthcare professionals prescribed home HFT to hypoxemic COPD patients during both sleep and daytime activities according to a ResMed internal survey.10

Yes. Flows and humidification have a positive peak inspiratory flow effect and oxygen is delivered more effectively during therapy, which is important during exercise.3​ HFT has been shown to improve dyspnoea during exercise.2-4 As the heated humidifier contains water, care must be taken at all times when moving the device.8

No, the HFT device must not be used in transit, e.g. on a plane, in a car or in a wheelchair. This is due to the risk that they will inhale water or that water will spill into the device and damage it.

Noise levels vary depending on the device and settings. Home high-flow therapy devices are designed to be used during sleep and to allow patients to talk and engage in daily life during therapy. ResMed’s Lumis HFT device has an operating volume of 38 dBA +/- 2 dBA with ClimateLineAir tubing and 39 dBA +/- 2 dBA when used with ClimateLineAir tubing and 5 L/min supplementary oxygen (measured in HFT mode according to ISO 80601-2-74:2017).

This content is intended for health professionals only. Please refer to the user and clinical guides for relevant information related to any warnings and precautions to be considered before and during use of the products.

* The 2023 GOLD COPD guidelines now recognise three GOLD groups – “A”, “B”, and “E”. Group “E” (formerly groups C and D) are patients with frequent exacerbations (defined as 2 or more in the past 12 months or 1 exacerbation requiring hospitalisation).

  1. Hasani A, et al. Domiciliary humidification improves lung mucociliary
    clearance in patients with bronchiectasis. Chron Respir Dis 2008;5:81-86.
  2. Cirio S, Piran M, Vitacca M, Piaggi G, Ceriana P, Prazzoli M, et al. Effects of heated and humidified high flow gases during high-intensity constant load exercise on severe COPD patients with ventilatory limitation. Respiratory Medicine 2016;118:128–32.
  3. Neunhäuserer D, Steidle-Kloc E, Weiss G, Kaiser B, Niederseer D, Hartl S, et al. Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease. The American Journal of Medicine 2016;129(11):1185–93.
  1. Chatila W, Nugent T, Vance G, Gaughan J, Criner GJ. The Effects of High- Flow vs Low-Flow Oxygen on Exercise in Advanced Obstructive Airways Disease. Chest 2004;126(4):1108–15.
  2. Fraser JF, et al. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax 2016;71:759-761.
  3. Storgaard LH, et al. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018;13:1195-1205.
  4. Rea H, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104:525-533.
  5. Nagata K, Kikuchi T, Horie T, Shiraki A, Kitajima T, Kadowaki T, et al. Domiciliary High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD Patients: A Multicenter, Randomized Crossover Trial. Annals of the American Thoracic Society. 2017.
  6. Spoletini G, Mega C, Pisani L, Alotaibi M, Khoja A, Price LL, Blasi F, Nava S, Hill NS. High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: A pilot randomized controlled trial. J Crit Care. 2018 Dec;48:418-425. doi: 10.1016/j.jcrc.2018.10.004. Epub 2018 Oct 5. PMID: 30321833.
  7. ResMed customer survey of healthcare professionals, conducted between 18/03/2021 – 31/06-2021 – Data on file; ID C306968